Duck myocardial cell line as well as construction method and application thereof

By constructing and optimizing the duck cardiomyocyte cell line, the problems of difficulty in isolation of avian virus antigens and wide variety of viruses in the prior art are solved, efficient cultivation of avian viruses and vaccine preparation are achieved, and effective tools for avian virus infection are provided. .

CN118995585AActive Publication Date: 2024-11-22GUANGZHOU BAISAI BIOMEDICAL TECHNOLOGY CO LTD
View PDF 3 Cites 0 Cited by

Patent Information

Application Number
CN202411276255.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-12
Publication Date
2024-11-22
Estimated Expiration
2044-09-12

AI Technical Summary

Technical Problem

The lack of immortalized cell lines suitable for avian virus growth in the prior art makes it difficult to isolate antigens of avian viruses, and there are many types of viruses and few commercial vaccines, especially the lack of the application of avian cells from different target organs in vaccine research and development. For example, it has not been used to develop duck cardiomyocytes.

Method used

Provide a duck cardiomyocyte cell line, called Madak cardiomyocyte SDMC, by isolating duck embryo heart, passing it with protease digestion and different culture media, the cell line is constructed and optimized for culturing, isolating, detecting avian viruses, and Prepare a viral vaccine.

Benefits of technology

The sensitivity culture and isolation of bursfaciens, avian adenovirus and type I duck viral hepatitis virus were achieved, and used to prepare avian vaccines, improve the research and development and production efficiency of avian virus vaccines, and provide for prevention or treatment. Drug screening tools for avian virus infection.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure HDA0005040271600000011
    Figure HDA0005040271600000011
  • Figure HDA0005040271600000012
    Figure HDA0005040271600000012
  • Figure HDA0005040271600000013
    Figure HDA0005040271600000013
Patent Text Reader

Abstract

The invention belongs to the field of biological medicines, and particularly relates to a duck myocardial cell line as well as a construction method and application thereof. The invention provides a duck myocardial cell line which is named as shelduck myocardial cell SDMC and is preserved in China Center for Type Culture Collection in Wuhan University, Wuhan, China on July 5, 2024, and the preservation number is CCTCC NO: C2024190. At present, 80 generations have been passed, and the form is mainly fusiform cells; a virus sensitivity test shows that the duck myocardial cell line is sensitive to bursal disease virus, fowl adenovirus and type I duck virus hepatitis virus; the cell line can be used for culturing, separating and detecting poultry viruses, preparing poultry vaccines and screening medicines for preventing or treating diseases caused by poultry virus infection.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of biomedicine, and specifically relates to a duck myocardial cell system and a construction method and application thereof. Background Art

[0002] my country has a large population and a large demand for poultry products, which has promoted the rapid development of the domestic poultry farming industry, with the scale of farming increasing and the number of varieties increasing. Poultry production has played an important role in promoting my country's economic development and improving the living standards of urban and rural residents. With the development of global economic integration and the demand for international trade, my country, as a major poultry country, has broad development space. However, in recent years, the complexity of poultry diseases has become a major factor that troubles and restricts the development of the poultry industry. According to relevant statistics, there are more than 80 diseases that pose a threat and harm to my country's poultry industry, involving infectious diseases, parasitic diseases, nutritional metabolic diseases and toxic diseases. Among them, infectious diseases are the most common, accounting for more than 75% of the total number of diseases, and the losses caused are also the greatest. Among infectious diseases, viral infectious diseases occur the most, accounting for about 70%, and there is a trend of increasing year by year. The occurrence of poultry diseases is still mainly viral infectious diseases. For example, the dominant diseases in chickens are Newcastle disease, avian influenza, Marek's disease, infectious bursal disease, infectious bronchitis and infectious laryngotracheitis, etc. The main diseases in ducks are duck plague, duck parvovirus disease, duck reovirus disease, duck viral hepatitis, etc. The main diseases in geese are gout, gosling plague, goose paramyxovirus disease, etc.

[0003] Vaccine immunization is undoubtedly the most effective way to prevent poultry diseases caused by infectious viruses. Cell culture is increasingly favored by vaccine producers in vaccine production. Compared with the traditional chicken embryo culture method, cell culture has many advantages in separating and culturing viruses: first, it can adapt to the large-scale culture required for production, with high output and relatively lower cost; second, the quality is controllable and the difference between batches is small; third, it can effectively exclude latent infection of viruses and is conducive to virus growth; fourth, it is easy to obtain and it is easy to select susceptible cells.

[0004] However, there are currently few immortalized cell lines suitable for the growth of avian viruses at home and abroad, which makes it difficult to isolate avian virus antigens. There are many types of viruses and relatively few commercial vaccines. In addition, there is a lack of application of avian cells from different target organs in the development of related vaccines, and there is currently no strain of duck cardiomyocytes for vaccine development. Summary of the invention

[0005] The first aspect of the present invention aims to provide a cell line.

[0006] The purpose of the second aspect of the present invention is to provide a method for constructing the cell line of the first aspect of the present invention.

[0007] The third aspect of the present invention aims to provide an application.

[0008] The fourth aspect of the present invention aims to provide a method for culturing viruses.

[0009] The fifth aspect of the present invention aims to provide a method for producing a viral vaccine.

[0010] The sixth aspect of the present invention aims to provide a viral vaccine.

[0011] In order to achieve the above-mentioned purpose of the present invention, the technical solution adopted by the present invention is:

[0012] The first aspect of the present invention provides a duck cardiomyocyte cell line, named Mallard duck cardiomyocyte cell SDMC, which was deposited in the China Type Culture Collection located at Wuhan University, Wuhan, China on June 28, 2024, with the deposit number CCTCCNO: C2024190.

[0013] The second aspect of the present invention provides a method for constructing a duck cardiomyocyte cell line according to the first aspect of the present invention, comprising the following steps:

[0014] 1) Isolate the duck embryo heart and cut it into tissue blocks;

[0015] 2) digesting the tissue block with a protease, separating the solid from the liquid, and culturing the cell pellet in a first culture medium;

[0016] 3) After the cells adhere, the culture medium is replaced with the second culture medium, and the cells are cultured and subcultured for 5 to 15 generations;

[0017] 4) using the third medium for culturing and subculturing for 5 to 15 generations;

[0018] 5) Using the fourth culture medium to culture, pass down for 5 to 15 generations to obtain.

[0019] Preferably, the first culture medium comprises 9-11 v / v% fetal bovine serum and a basal culture medium.

[0020] Preferably, the second culture medium comprises 7-9 v / v% fetal bovine serum, 0.05-0.15 mmol / L BrdU, and a basal culture medium.

[0021] Preferably, the third culture medium comprises 4-6 v / v% fetal bovine serum and a basal culture medium.

[0022] Preferably, the fourth culture medium comprises 2-3 v / v% fetal bovine serum and a basal culture medium.

[0023] Preferably, the basal culture medium includes at least one of MEM culture medium, DMEM culture medium and DMEM / F12 culture medium.

[0024] In one embodiment of the present invention, the construction method comprises: 1) taking 3 duck embryos aged 7-9 days, isolating the heart under sterile conditions, cutting the heart tissue into pieces, performing a first digestion with pancreatic enzyme, discarding the digestion solution, and performing a second digestion with pancreatic enzyme to obtain tissue fragments and a cell suspension; 2) adding the suspension to a centrifuge tube containing a first culture medium, mixing, filtering with a stainless steel filter screen to remove tissue fragments, obtaining a cell suspension, adding the first culture medium to re-cell, using a differential attachment method, culturing statically for 1 hour, and then aspirating the cell suspension (without shaking) and continuing static culturing; 3) the cells After the cells grow in adherence, the second culture medium is replaced for culture. After the cells grow into a monolayer, they are digested with trypsin and then inoculated into a culture plate at a density of 0.1 to 1 cell / well. Cells with good growth and obvious beating in a single cell well are grown into clones to obtain duck myocardial single cell lines; 4) The duck myocardial single cell line is digested with trypsin, subcultured, and after the cells grow into a monolayer, they are digested and centrifuged to obtain cell pellets, which are cultured with the third culture medium to obtain serum-reduced duck myocardial cells; 4) The serum-reduced duck myocardial cells are cultured with the fourth culture medium to obtain a low-serum adherent culture type duck myocardial cell line.

[0025] Preferably, the size of the tissue fragments in step 1) is 1 to 2 cm 3 / indivual.

[0026] Preferably, the culture conditions are 31-39° C., 4-6% CO 2 ; further preferably 33-37° C., 5% CO 2 .

[0027] The third aspect of the present invention is to provide the use of the duck cardiomyocyte cell line of the first aspect of the present invention in any one of 1) to 8):

[0028] 1) Cultivate the virus;

[0029] 2) Preparation of products for cultured viruses;

[0030] 3) Isolation of viruses;

[0031] 4) Preparation of virus isolation products;

[0032] 5) Virus testing for non-diagnostic treatment destinations;

[0033] 6) Preparation of products for detecting viruses;

[0034] 7) Preparation of viral vaccines;

[0035] 8) Drug screening;

[0036] The medicine is a medicine used for preventing or treating diseases caused by viral infection.

[0037] Preferably, the virus comprises at least one of bursal disease virus, avian adenovirus and duck viral hepatitis virus type I.

[0038] Preferably, the bursal disease virus is IBDV-X1.

[0039] Preferably, the avian adenovirus is FAdV-4.

[0040] Preferably, the type I duck viral hepatitis virus is DHV-1C80.

[0041] The fourth aspect of the present invention provides a method for culturing a virus, comprising inoculating the virus into the duck cardiomyocyte cell line of the first aspect of the present invention and culturing the virus.

[0042] Preferably, the virus comprises at least one of bursal disease virus, avian adenovirus and duck viral hepatitis virus type I.

[0043] Preferably, the bursal disease virus is IBDV-X1.

[0044] Preferably, the avian adenovirus is FAdV-4.

[0045] Preferably, the type I duck viral hepatitis virus is DHV-1C80.

[0046] Preferably, the culture conditions are 31-39° C., 4-6% CO 2 ; further preferably 33-37° C., 5% CO 2 .

[0047] The fifth aspect of the present invention provides a method for preparing a viral vaccine, comprising inoculating the virus into the duck myocardial cell line of the first aspect of the present invention, culturing, and inactivating the virus to obtain the viral vaccine.

[0048] Preferably, the virus comprises at least one of bursal disease virus, avian adenovirus and duck viral hepatitis virus type I.

[0049] Preferably, the bursal disease virus is IBDV-X1.

[0050] Preferably, the avian adenovirus is FAdV-4.

[0051] Preferably, the type I duck viral hepatitis virus is DHV-1C80.

[0052] Preferably, the culture conditions are 31-39° C., 4-6% CO 2 ; further preferably 33-37° C., 5% CO 2 .

[0053] The sixth aspect of the present invention provides a viral vaccine prepared by the method of the fifth aspect of the present invention.

[0054] The beneficial effects of the present invention are:

[0055] The invention provides a Mallard myocardial cell SDMC, which has been propagated to the 80th generation and is mainly in the form of spindle cells; virus sensitivity tests show that the duck myocardial cell line is sensitive to bursal disease virus, avian adenovirus and duck viral hepatitis virus type I; the cell line can be used to culture, separate and detect avian viruses, prepare avian vaccines, and screen drugs for preventing or treating diseases caused by avian virus infections. BRIEF DESCRIPTION OF THE DRAWINGS

[0056] Figure 1 This is the result of normal culture of Mallard duck cardiomyocytes SDMC at the 30th generation.

[0057] Figure 2 This is the result of inoculating duck cardiomyocytes SDMC with IBDV-X1 strain at a dose of 2.5‰ for 47 hours in Example 3.

[0058] Figure 3 This is the result graph of the duck cardiomyocytes SDMC in Example 4 after being inoculated with the FAdV-4 strain at a dose of 1‰ for 40 hours.

[0059] Figure 4 This is the result of inoculating duck cardiomyocytes SDMC with FAdV-4 strain at a dose of 2.5‰ for 36 hours in Example 4.

[0060] Figure 5 This is the result graph of the duck cardiomyocytes SDMC in Example 5 after being inoculated with DHV-1C80 strain at a dose of 1‰ for 65 hours.

[0061] Figure 6 This is the result of inoculating duck cardiomyocytes SDMC with DHV-1C80 strain at a dose of 5‰ for 44 hours in Example 5. DETAILED DESCRIPTION

[0062] The following will be combined with the embodiments to clearly and completely describe the concept of the present invention and the technical effects produced, so as to fully understand the purpose, characteristics and effects of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of them. Based on the embodiments of the present invention, other embodiments obtained by those skilled in the art without creative work are all within the scope of protection of the present invention.

[0063] Example 1

[0064] 1. Isolation and culture of primary duck cardiomyocytes:

[0065] (1) Take five duck embryos that have been hatched to 8 days old and mark the position of the air chamber and embryo body;

[0066] (2) Place the embryonated egg on the egg rack, clean the eggshell with warm water, and then wipe it dry with a 75% alcohol cotton ball;

[0067] (3) Under sterile conditions, use tweezers to open the air chamber, carefully remove the eggshell with tweezers to expose the embryo, remove the embryo with bent tweezers, and place it in a sterile dish;

[0068] (4) Use forceps to gently lift the embryo's chest and abdominal skin, and then use ophthalmic scissors to cut open the embryo's chest and abdominal skin to expose the heart;

[0069] (5) Use ophthalmic scissors to separate the heart, place it in a clean sterile dish, cut off the blood vessels and connective tissue, wash it three times with pre-cooled D-Hank's solution, and cut the heart tissue into 1-2 mm 3 Small pieces of size;

[0070] (6) Wash the tissue fragments obtained in step (5) three times in D-Hank's solution, add 3 mL of 2.5 g / L pancreatic enzyme and act for 10 min, and discard the digestion solution;

[0071] (7) Add 3 mL of 2.5 g / L pancreatin to the tissue fragments obtained in step (6) and act for 20 min. Use a pipette to disperse the cells, and quickly add the cell suspension to a centrifuge tube containing 7 mL of growth medium (MEM culture medium containing 100 mL / L serum), and mix by repeated pipetting;

[0072] (8) Filter the suspension obtained in step (7) through a 200-mesh stainless steel filter to remove tissue fragments, then centrifuge the filtered cell fluid at 800 r / min for 10 min, discard the supernatant, add 10 mL of growth medium (MEM culture medium containing 100 mL / L serum), resuspend the cells, add to a 25 mL cell culture flask, and culture in a 37° C. 5% CO2 incubator;

[0073] (9) The cell solution in step (8) was incubated for 1 h, and then the cell suspension was aspirated (do not shake), and the cell suspension was added to another cell culture bottle, which was placed in a 37°C 5% CO2 incubator for static culture.

[0074] 2. Obtaining duck cardiomyocytes:

[0075] (1) After the cells have been attached to the wall for 12 h in step 1, the original culture medium was discarded, the cells were washed three times with growth medium, and then 10 mL of growth medium (MEM culture medium containing 0.1 mmol / L BrdU and 100 mL / L serum) was added. The cells were cultured in a 37°C 5% CO2 incubator. Half of the culture supernatant was discarded every 24 h, and an equal amount of culture medium was added. The cell growth was observed under an inverted microscope;

[0076] (2) After the cells have grown into a monolayer, discard the culture medium, wash once with 2.5 g / L trypsin, and then digest with trypsin to single cells. Inoculate them into a 96-well plate at an average density of 0.5 cells / well, mark the wells where single cells are inoculated, and select cells that grow well and have obvious beating to grow into clones, thus obtaining a duck cardiomyocyte cell line.

[0077] 3. Subculture and acclimatization of duck cardiomyocytes: Digest the clumped single cell strain with 5g / L trypsin solution for 30s, then subculture for 10 generations to obtain a duck cardiomyocyte strain with uniform morphology.

[0078] 4. Serum-reduced passage and acclimation of duck cardiomyocytes: After the duck cardiomyocyte adherent cells in step 3 grow into a monolayer, the duck cardiomyocyte adherent cells are dispersed by digestion with 0.25wt% EDTA-trypsin, and the cell pellet is obtained by centrifugation at 1000rpm for 5min. The cell pellet is cultured in MEM medium containing 5% fetal bovine serum at 37°C and 5% CO2. After 5 generations of continuous culture, the serum-reduced duck cardiomyocytes are obtained.

[0079] 5. Low serum acclimation of duck cardiomyocytes: The last generation of duck cardiomyocytes cultured in step 4 was directly replaced with MEM culture medium containing 2.5% fetal bovine serum and cultured for 10 generations at 37°C and 5% CO2 to obtain a low serum adherent culture type duck cardiomyocyte cell line.

[0080] During the construction of the low-serum adherent culture duck cardiomyocyte cell line, the cells were frozen and stored every 5 passages to establish a cell bank.

[0081] The above-mentioned low-serum adherent cultured duck cardiomyocyte cell line was named Mallard duck cardiomyocyte cell SDMC. When it was passaged to the 35th generation, it was preserved in the China Type Culture Collection located at Wuhan University, Wuhan, China on June 28, 2024, with the preservation number CCTCC NO: C2024190.

[0082] Example 2 Characteristics of duck cardiomyocytes SDMC

[0083] Morphological observation:

[0084] The cell morphology of the 30th generation duck cardiomyocyte cell line was observed under an inverted microscope. Figure 1 As shown: The cells are spindle-shaped, with clear cytoplasm and full morphology, and the nucleus is round and located in the center. They can merge into a single layer 3 to 4 days after subculture.

[0085] Example 3 Susceptibility of duck myocardial cell line infected by bursal disease virus

[0086] The 30th generation of duck cardiomyocytes SDMC cells were cultured at 37°C and 5% CO2 for 48 h. After the cells grew stably, most of the culture medium was discarded in the clean bench, leaving only 1 mL. 10 μL, 25 μL and 50 μL of IBDV-X1 (TCID 50 =10 -8.5 / 0.1mL) strain (published in the literature: Xiang Rui. Study on the immune protection effect of recombinant protein of Newcastle disease, avian influenza, and infectious bursal disease virus [D]. Northwest A&F University, 2021.) was incubated for 30 minutes, and 10mL of MEM medium containing 2.5% fetal bovine serum was added after discarding the liquid in the bottle. The 30th generation of duck cardiomyocytes in Example 2 was used as a control. 24 hours after infection (the culture conditions after infection were 37°C and 5% CO2), the cell pathological changes were observed every 2 to 3 hours, and the cell venom was collected for TCID 50 Test. The results are as follows Figure 1 , Figure 2 As shown in Table 1: In the control group, the surface of the duck cardiomyocyte SDMC was smooth and plump, and the shape was spindle-shaped. It could grow fully in about 48 hours under normal passage. After inoculation with bursal disease virus, pathological phenomena appeared: the edges of the cells began to shrink, the cells still attached to the bottom of the bottle were in a thread-like shape, and most of the cells fell off and attached to the surface. After 51 hours of inoculation of duck cardiomyocytes at a dose of 1‰, the TCID 50 Reach 10 -7.32 / 0.1mL, 47h after exposure to 2.5‰ of the toxin, TCID 50 Reach 10 -7.83 / 0.1mL, 35h after exposure to 5‰ of the toxin, TCID 50 Reach 10 -7.0 / 0.1mL; it can be seen that duck cardiomyocytes are sensitive to bursal disease virus.

[0087] Table 1 Results of duck myocardial cells inoculated with IBDV-X1 strain

[0088] IBDV-X1 strain inoculation Drug collection time <![CDATA[TCID 50 ]]> 10μL(1‰) 51h <![CDATA[10 -7.32 / 0.1mL]]> 25μL (2.5‰) 47h <![CDATA[10 -7.83 / 0.1mL]]> 50μL(5‰) 35h <![CDATA[10 -7.0 / 0.1mL]]>

[0089] Example 4 Susceptibility of duck myocardial cell line infected by avian adenovirus

[0090] The 30th generation of duck cardiomyocytes SDMC cells were cultured at 37°C and 5% CO2 for 48 h. After the cells grew stably, most of the culture medium was discarded in the clean bench, leaving only 1 mL. 10 μL, 25 μL and 50 μL of FAdV-4 (TCID 50 =10 -8.0 / 0.1ml) strain (published in the literature: Wu Ning. Study on the expression changes of early miRNAs and mRNAs in LMH cells infected with avian adenovirus serotype 4 [D]. Northwest A&F University, 2020.)) for 30 minutes, discard the liquid in the bottle and add 10mL of MEM medium containing 2.5% fetal bovine serum, and use the control group in Example 3 as a control. 24 hours after infection (the culture conditions after infection were 37°C and 5% CO2), observe the cytopathic condition every 2 to 3 hours, and collect the cytotoxic fluid for TCID 50 Test. The results are as follows Figure 3 , Figure 4 As shown in Table 2: In the control group, the surface of duck cardiomyocytes was smooth and plump, and the shape was spindle-shaped. They could grow full in about 48 hours under normal passage. After inoculation with avian adenovirus, pathological phenomena appeared: cells shrank, most of the cells became round and fell off, and attached to the surface. After duck cardiomyocytes were inoculated with 1‰ of the virus for 48 hours, the TCID 50 Reach 10 -7.0 / 0.1mL, 42h after exposure to 2.5‰ of the toxin, TCID 50 Reach 10 -7.5 / 0.1mL, 24h after exposure to 5‰ of the toxin, TCID 50 Reach 10 -7.16 / 0.1mL; it can be seen that duck cardiomyocytes are sensitive to avian adenovirus.

[0091] Table 2 Results of duck myocardial cells inoculated with FAdV-4 strain

[0092] FAdV-4 strain inoculation dose Drug collection time <![CDATA[TCID 50 ]]> 10μL(1‰) 48h <![CDATA[10 -7.0 / 0.1mL]]> 25μL (2.5‰) 42h <![CDATA[10 -7.5 / 0.1mL <!-- 5 -->]]> 50μL(5‰) 24h <![CDATA[10 -7.16 / 0.1mL]]>

[0093] Example 5 Susceptibility of duck myocardial cell line to infection by duck viral hepatitis virus type Ⅰ

[0094] Duck myocardial cell line passage 30 cells were cultured at 37°C and 5% CO2 for 48 h until the cells grew stably. Most of the culture medium was discarded in the clean bench, leaving only 1 mL. 25 μL and 50 μL of DHV-1C80 strain (TCID 50 =10 -3.6 / 0.1ml) strain (disclosed in the literature: Wang Wenxiu, Zhang Qian, Qu Guanggang, et al. Establishment of SYBR-Green real-time fluorescence quantitative PCR detection method for duck hepatitis virus type I [J]. Chinese Journal of Veterinary Medicine, 2014, 34(08): 1248-1252.) was incubated for 30 minutes, and 10 mL of MEM medium containing 2.5% fetal bovine serum was added after discarding the liquid in the bottle. The control group in Example 3 was used as a control. 24 hours after infection (the culture conditions after infection were 37°C and 5% CO2), the cell pathological changes were observed every 2 to 3 hours, and the cell venom was collected for TCID 50 Test. The results are as follows Figure 5 , Figure 6 As shown in Table 3: In the control group, the surface of duck myocardial cells was smooth and plump, and the shape was spindle-shaped. They could grow full in about 48 hours under normal passage. After inoculation of avian adenovirus, pathological phenomena appeared: cells shrank, most of the cells became round and fell off, and the fallen cells had agglomeration phenomenon. After duck myocardial cells were inoculated with 1‰ of the virus for 65 hours, TCID 50 Reach 10 -3.2 / 0.1mL, 60h after exposure to 2.5‰ of the toxin, TCID 50 Reach 10 -3.5 / 0.1mL, 48h after exposure to 5‰ of the toxin, TCID 50 Reach 10 -4.16 / 0.1mL; it can be seen that duck cardiomyocytes are sensitive to avian adenovirus.

[0095] Table 3 Results of duck myocardial cells inoculated with DHV-1C80 strain

[0096] FAdV-4 strain inoculation dose Drug collection time <![CDATA[TCID 50 ]]> 10μL(1‰) 65h <![CDATA[10 -3.2 / 0.1mL]]> 25μL (2.5‰) 60h <![CDATA[10 -3.5 / 0.1mL]]> 50μL(5‰) 48h <![CDATA[10 -4.16 / 0.1mL]]>

Claims

1. A duck cardiomyocyte cell line, named Mallard duck cardiomyocyte cell SDMC, was deposited in the China Type Culture Collection, Wuhan University, Wuhan, China on June 28, 2024, with the deposit number CCTCC NO: C2024190.

2. The method for constructing the duck cardiomyocyte cell line according to claim 1, The following steps are involved: 1) Isolate the duck embryo heart and cut it into tissue blocks; 2) digesting the tissue block with a protease, separating the solid from the liquid, and culturing the cell pellet in a first culture medium; 3) After the cells adhere, the culture medium is replaced with the second culture medium, and the cells are cultured and subcultured for 5 to 15 generations; 4) using the third medium for culturing and subculturing for 5 to 15 generations; 5) Using the fourth culture medium to culture, pass down for 5 to 15 generations to obtain.

3. The construction method according to claim 2, Features: The first culture medium comprises 9-11 v / v% fetal bovine serum and a basal culture medium; and / or The second culture medium comprises 7-9 v / v% fetal bovine serum, 0.05-0.15 mmol / L BragU, and a basal culture medium; and / or The third culture medium comprises 4-6 v / v% fetal bovine serum and a basal culture medium; and / or The fourth culture medium includes 2-3 v / v% fetal bovine serum and a basal culture medium.

4. The construction method according to claim 3, Features: The basic culture medium includes at least one of MEM culture medium, DMEM culture medium and DMEM / F12 culture medium.

5. Use of the duck cardiomyocyte cell line according to claim 1 in any one of 1) to 8): 1) Cultivate the virus; 2) Preparation of products for cultured viruses; 3) Isolation of viruses; 4) Preparation of virus isolation products; 5) Virus testing for non-diagnostic treatment destinations; 6) Preparation of products for detecting viruses; 7) Preparation of viral vaccines; 8) Drug screening; The medicine is a medicine used for preventing or treating diseases caused by viral infection.

6. The use according to claim 5, Features: The virus comprises at least one of bursal disease virus, avian adenovirus and duck viral hepatitis virus type I.

7. A method for culturing a virus, comprising inoculating the virus into the duck myocardial cell line of claim 1 and culturing the virus.

8. A method for preparing a virus vaccine, comprising inoculating the virus into the duck myocardial cell line of claim 1, culturing, and inactivating the virus to obtain the virus vaccine.

9. The method according to claim 7 or 8, Features: The virus comprises at least one of bursal disease virus, avian adenovirus and duck viral hepatitis virus type I.

10. A viral vaccine prepared by the method of claim 8 or 9.

Citation Information

Patent Citations

  • Cherry valley duck fibroblast cell line as well as construction method and application thereof

    CN114350601A

  • Attenuated duck hepatitis virus strains, method of separating duck hepatitis virus and preparing process using the same

    KR1020090012686A

  • Duck embryonic derived stem cell lines for the production of viral vaccines

    US20100062489A1